Evidence map›Paper›PMID 11757584›Full record

ArticleJournal of inherited metabolic disease2001

Phenotype variability in 130 adult patients with respiratory chain disorders.

J Finsterer, C Jarius, H Eichberger

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Journal of inherited metabolic disease, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 62 citations in OpenAlex.

  1. Reproducibility of the lactate stress test.Metabolic brain disease · 2003
    Trial
  2. Cholesterol in Mitochondrial Diseases-Friend or Foe?International journal of molecular sciences · 2026
    Review
  3. Article
  4. Article
  5. Complex-I defect with minimal manifestations.Archives of medical science : AMS · 2014
    Article
  6. Review
  7. Article
  8. Neuromuscular and systemic presentations in adults: diagnoses beyond MERRF and MELAS.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2013
    Review
  9. Article
  10. Review
  11. Article
  12. Mitochondrial Myopathy in Follow-up of a Patient With Chronic Fatigue Syndrome.Journal of investigative medicine high impact case reports
    Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

J FinstererNeurological Department, Neurological Hospital Rosenhügel, Ludwig Boltzmann Institute for Epilepsy and Neuronmuscular Disorders, Vienna, Austria.
C Jarius
H Eichberger
University of Vienna · ATSigmund Freud University Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite continuously improving diagnostic facilities, respiratory chain disorders (RCDs) are easily overlooked or misdiagnosed. We thus studied phenotype variability and the diagnostic potential of clinical and laboratory investigations in patients with RCD. We retrospectively evaluated clinical and laboratory investigations in 130 patients with RCD: 63 women and 67 men, aged 17-87 years, diagnosed between January 1992 and December 1999. mtDNA mutations were found in 20 patients; a respiratory chain defect but no mutation in 4; an abnormal lactate stress test but no mutation or biochemical defect in 66; and ragged-red fibres or reduced oxidative enzyme staining but no mutation, biochemical defect or abnormal lactate stress test in 40 patients. The most frequent initial manifestation of RCD were limb weakness, muscle pain and sensory disturbances. The most frequent clinical findings at diagnosis were muscle pain, fatiguability, limb weakness, reduced tendon reflexes and muscle wasting, irrespective of the diagnostic evidence. Mean age at onset, disease duration and time until diagnosis were 39, 14 and 13 years, respectively, without sex differences. The family history was positive in 29% of the patients. Hyperlipidaemia was found in 45%, hyper-CK-aemia in 42%, short stature in 33%, thyroid dysfunction in 17%, diabetes in 12%, and epilepsy in 8% of the patients. Laboratory investigations that prove useful to support the diagnosis of RCD are muscle biopsy, electromyography, lactate stress testing, echocardiography and mtDNA analysis. Systems most often involved in RCDs were the PNS, CNS, endocrine system and heart. The diagnosis of RCD requires awareness of the great phenotypic heterogeneity and an individualized, integral, multidisciplinary approach.

Indexed as

AdolescentAdultAgedAged, 80 and overAge of OnsetAgingBody HeightDisease ProgressionDNA, MitochondrialElectron TransportEnzymesFemaleGene FrequencyHumansMaleMetabolism, Inborn ErrorsDNA, MitochondrialEnzymes

Identifiers

PMID11757584
OpenAlexW1521592277

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.